- Home
- HLF vs IMTX Comparison
HLF vs IMTX Comparison
Compare HLF & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLF
- IMTX
- Stock Information
- Founded
- HLF 1980
- IMTX N/A
- Country
- HLF United States
- IMTX Germany
- Employees
- HLF N/A
- IMTX N/A
- Industry
- HLF Other Pharmaceuticals
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLF Health Care
- IMTX Health Care
- Exchange
- HLF Nasdaq
- IMTX Nasdaq
- Market Cap
- HLF 583.2M
- IMTX 559.1M
- IPO Year
- HLF N/A
- IMTX N/A
- Fundamental
- Price
- HLF $8.33
- IMTX $4.60
- Analyst Decision
- HLF Buy
- IMTX Strong Buy
- Analyst Count
- HLF 5
- IMTX 4
- Target Price
- HLF $9.90
- IMTX $16.67
- AVG Volume (30 Days)
- HLF 3.7M
- IMTX 1.2M
- Earning Date
- HLF 02-19-2025
- IMTX 03-20-2025
- Dividend Yield
- HLF N/A
- IMTX N/A
- EPS Growth
- HLF 76.06
- IMTX N/A
- EPS
- HLF 2.50
- IMTX N/A
- Revenue
- HLF $4,993,100,000.00
- IMTX $128,824,447.00
- Revenue This Year
- HLF N/A
- IMTX $116.22
- Revenue Next Year
- HLF $1.57
- IMTX N/A
- P/E Ratio
- HLF $3.32
- IMTX N/A
- Revenue Growth
- HLF N/A
- IMTX 52.53
- 52 Week Low
- HLF $5.04
- IMTX $4.48
- 52 Week High
- HLF $12.79
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- HLF 77.90
- IMTX 27.20
- Support Level
- HLF $5.57
- IMTX $4.85
- Resistance Level
- HLF $8.40
- IMTX $5.25
- Average True Range (ATR)
- HLF 0.39
- IMTX 0.28
- MACD
- HLF 0.34
- IMTX -0.01
- Stochastic Oscillator
- HLF 97.77
- IMTX 8.96
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management; targeted nutrition; Energy, Sports, and Fitness; Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Mexico, South and Central America, EMEA, Asia-Pacific, and China.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.